News Daily News Black Patients With Chest Pain Differ From Whites, but Risks Are Similar Michael O'Riordan December 23, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels Michael O'Riordan December 22, 2021
News Daily News Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk Todd Neale December 22, 2021
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021
News Features Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign L.A. McKeown December 20, 2021
News Daily News New Insights Into Myocarditis and mRNA COVID-19 Vaccines Yael L. Maxwell December 17, 2021
News Features As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years Caitlin E. Cox December 16, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Daily News New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT Michael O'Riordan December 09, 2021
News Daily News The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI Caitlin E. Cox December 09, 2021
News Daily News New Scientific Statement Seeks to Standardize Cardiac Surgery Trials Yael L. Maxwell December 08, 2021
News Features US Chest Pain Guidelines Will Change Practice, Though Gaps Remain Yael L. Maxwell December 06, 2021
News Daily News Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk Todd Neale December 03, 2021
News Daily News Cardiopulmonary Tests Urged for Lasting Fatigue, Dyspnea After COVID-19 Todd Neale December 02, 2021
News Daily News Point-of-Care hs-cTn Tests for MI Rule-out Could Save Time, Resources Yael L. Maxwell December 01, 2021
News Daily News Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis Yael L. Maxwell November 23, 2021
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021